カテゴリー： 世界, 医療/バイオ, LP Information

世界の狂犬病免疫グロブリン（馬）市場予測 2023年-2029年

【英語タイトル】Global Rabies Immune Globulin (Equine) Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC04616）・商品コード：LP23DC04616
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：104
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥549,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥823,500見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,098,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の狂犬病免疫グロブリン（馬）市場」は、過去の販売実績から2022年の世界の狂犬病免疫グロブリン（馬）の総販売量を検討し、2023年から2029年の予測される狂犬病免疫グロブリン（馬）の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の狂犬病免疫グロブリン（馬）の市場規模を掲載し、XXX百万米ドル規模の世界の狂犬病免疫グロブリン（馬）市場の詳細な分析を提供します。本インサイトレポートは、世界の狂犬病免疫グロブリン（馬）業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の狂犬病免疫グロブリン（馬）市場における各社の独自のポジションをより深く理解するために、狂犬病免疫グロブリン（馬）製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の狂犬病免疫グロブリン（馬）市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。狂犬病免疫グロブリン（馬）の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。狂犬病免疫グロブリン（馬）の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。狂犬病免疫グロブリン（馬）のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

狂犬病免疫グロブリン（馬）の世界主要メーカーとしては、Grifols、 Serum China、 Premium Serums、 Intas、 Aventis Pasteur India、 Cadila Pharmaceuticals、 Zydus Takeda Healthcare、 Bharat Serums And Vaccines、 GlaxoSmithKline GmbH、 VINS Bioproducts、 CSL Behringなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の狂犬病免疫グロブリン（馬）市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では狂犬病免疫グロブリン（馬）市場をセグメンテーションし、種類別 (1500IU、1000IU、400IU、その他)、用途別 (診療所、病院)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：1500IU、1000IU、400IU、その他

・用途別区分：診療所、病院

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の狂犬病免疫グロブリン（馬）市場の10年間の市場状況・展望は？
・世界および地域別に見た狂犬病免疫グロブリン（馬）市場成長の要因は何か？
・狂犬病免疫グロブリン（馬）の市場機会はエンドマーケットの規模によってどのように変化するのか？
・狂犬病免疫グロブリン（馬）のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：狂犬病免疫グロブリン（馬）の年間販売量2018-2029、地域別現状・将来分析
・狂犬病免疫グロブリン（馬）の種類別セグメント：1500IU、1000IU、400IU、その他
・狂犬病免疫グロブリン（馬）の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・狂犬病免疫グロブリン（馬）の用途別セグメント：診療所、病院
・狂犬病免疫グロブリン（馬）の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の狂犬病免疫グロブリン（馬）市場
・企業別のグローバル狂犬病免疫グロブリン（馬）市場データ：2018-2023年の年間販売量、市場シェア
・企業別の狂犬病免疫グロブリン（馬）の年間売上：2018-2023年の売上、市場シェア
・企業別の狂犬病免疫グロブリン（馬）販売価格
・主要企業の狂犬病免疫グロブリン（馬）生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

狂犬病免疫グロブリン（馬）の地域別レビュー
・地域別の狂犬病免疫グロブリン（馬）市場規模2018-2023：年間販売量、売上
・主要国別の狂犬病免疫グロブリン（馬）市場規模2018-2023：年間販売量、売上
・南北アメリカの狂犬病免疫グロブリン（馬）販売の成長
・アジア太平洋の狂犬病免疫グロブリン（馬）販売の成長
・ヨーロッパの狂犬病免疫グロブリン（馬）販売の成長
・中東・アフリカの狂犬病免疫グロブリン（馬）販売の成長

南北アメリカ市場
・南北アメリカの国別の狂犬病免疫グロブリン（馬）販売量、売上（2018-2023）
・南北アメリカの狂犬病免疫グロブリン（馬）の種類別販売量
・南北アメリカの狂犬病免疫グロブリン（馬）の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の狂犬病免疫グロブリン（馬）販売量、売上（2018-2023）
・アジア太平洋の狂犬病免疫グロブリン（馬）の種類別販売量
・アジア太平洋の狂犬病免疫グロブリン（馬）の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の狂犬病免疫グロブリン（馬）販売量、売上（2018-2023）
・ヨーロッパの狂犬病免疫グロブリン（馬）の種類別販売量
・ヨーロッパの狂犬病免疫グロブリン（馬）の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の狂犬病免疫グロブリン（馬）販売量、売上（2018-2023）
・中東・アフリカの狂犬病免疫グロブリン（馬）の種類別販売量
・中東・アフリカの狂犬病免疫グロブリン（馬）の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・狂犬病免疫グロブリン（馬）の製造コスト構造分析
・狂犬病免疫グロブリン（馬）の製造プロセス分析
・狂犬病免疫グロブリン（馬）の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・狂犬病免疫グロブリン（馬）の主要なグローバル販売業者
・狂犬病免疫グロブリン（馬）の主要なグローバル顧客

地域別の狂犬病免疫グロブリン（馬）市場予測レビュー
・地域別の狂犬病免疫グロブリン（馬）市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・狂犬病免疫グロブリン（馬）の種類別市場規模予測
・狂犬病免疫グロブリン（馬）の用途別市場規模予測

主要企業分析
Grifols、 Serum China、 Premium Serums、 Intas、 Aventis Pasteur India、 Cadila Pharmaceuticals、 Zydus Takeda Healthcare、 Bharat Serums And Vaccines、 GlaxoSmithKline GmbH、 VINS Bioproducts、 CSL Behring
・企業情報
・狂犬病免疫グロブリン（馬）製品
・狂犬病免疫グロブリン（馬）販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Rabies Immune Globulin (Equine) market size is projected to grow from US$ 1173.9 million in 2022 to US$ 1506.8 million in 2029; it is expected to grow at a CAGR of 3.6% from 2023 to 2029.
Rabies Immune Globulin (Equine) is a medication used to prevent rabies infection in people who have been exposed to the virus. It is made from the blood of horses that have been immunized against rabies.

The development of Rabies Immune Globulin (Equine) involved the isolation and purification of antibodies from the blood of immunized horses. The process includes collecting blood from the horses, separating the plasma from the red blood cells, and purifying the antibodies using various techniques.
LPI (LP Information)’ newest research report, the “Rabies Immune Globulin (Equine) Industry Forecast” looks at past sales and reviews total world Rabies Immune Globulin (Equine) sales in 2022, providing a comprehensive analysis by region and market sector of projected Rabies Immune Globulin (Equine) sales for 2023 through 2029. With Rabies Immune Globulin (Equine) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rabies Immune Globulin (Equine) industry.
This Insight Report provides a comprehensive analysis of the global Rabies Immune Globulin (Equine) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rabies Immune Globulin (Equine) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rabies Immune Globulin (Equine) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rabies Immune Globulin (Equine) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rabies Immune Globulin (Equine).
This report presents a comprehensive overview, market shares, and growth opportunities of Rabies Immune Globulin (Equine) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
1500IU
1000IU
400IU
Others
Segmentation by application
Clinic
Hospital
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Grifols
Serum China
Premium Serums
Intas
Aventis Pasteur India
Cadila Pharmaceuticals
Zydus Takeda Healthcare
Bharat Serums And Vaccines
GlaxoSmithKline GmbH
VINS Bioproducts
CSL Behring
Key Questions Addressed in this Report
What is the 10-year outlook for the global Rabies Immune Globulin (Equine) market?
What factors are driving Rabies Immune Globulin (Equine) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rabies Immune Globulin (Equine) market opportunities vary by end market size?
How does Rabies Immune Globulin (Equine) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rabies Immune Globulin (Equine) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Rabies Immune Globulin (Equine) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Rabies Immune Globulin (Equine) by Country/Region, 2018, 2022 & 2029
2.2 Rabies Immune Globulin (Equine) Segment by Type
2.2.1 1500IU
2.2.2 1000IU
2.2.3 400IU
2.2.4 Others
2.3 Rabies Immune Globulin (Equine) Sales by Type
2.3.1 Global Rabies Immune Globulin (Equine) Sales Market Share by Type (2018-2023)
2.3.2 Global Rabies Immune Globulin (Equine) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Rabies Immune Globulin (Equine) Sale Price by Type (2018-2023)
2.4 Rabies Immune Globulin (Equine) Segment by Application
2.4.1 Clinic
2.4.2 Hospital
2.5 Rabies Immune Globulin (Equine) Sales by Application
2.5.1 Global Rabies Immune Globulin (Equine) Sale Market Share by Application (2018-2023)
2.5.2 Global Rabies Immune Globulin (Equine) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Rabies Immune Globulin (Equine) Sale Price by Application (2018-2023)
3 Global Rabies Immune Globulin (Equine) by Company
3.1 Global Rabies Immune Globulin (Equine) Breakdown Data by Company
3.1.1 Global Rabies Immune Globulin (Equine) Annual Sales by Company (2018-2023)
3.1.2 Global Rabies Immune Globulin (Equine) Sales Market Share by Company (2018-2023)
3.2 Global Rabies Immune Globulin (Equine) Annual Revenue by Company (2018-2023)
3.2.1 Global Rabies Immune Globulin (Equine) Revenue by Company (2018-2023)
3.2.2 Global Rabies Immune Globulin (Equine) Revenue Market Share by Company (2018-2023)
3.3 Global Rabies Immune Globulin (Equine) Sale Price by Company
3.4 Key Manufacturers Rabies Immune Globulin (Equine) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rabies Immune Globulin (Equine) Product Location Distribution
3.4.2 Players Rabies Immune Globulin (Equine) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Rabies Immune Globulin (Equine) by Geographic Region
4.1 World Historic Rabies Immune Globulin (Equine) Market Size by Geographic Region (2018-2023)
4.1.1 Global Rabies Immune Globulin (Equine) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Rabies Immune Globulin (Equine) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Rabies Immune Globulin (Equine) Market Size by Country/Region (2018-2023)
4.2.1 Global Rabies Immune Globulin (Equine) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Rabies Immune Globulin (Equine) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Rabies Immune Globulin (Equine) Sales Growth
4.4 APAC Rabies Immune Globulin (Equine) Sales Growth
4.5 Europe Rabies Immune Globulin (Equine) Sales Growth
4.6 Middle East & Africa Rabies Immune Globulin (Equine) Sales Growth
5 Americas
5.1 Americas Rabies Immune Globulin (Equine) Sales by Country
5.1.1 Americas Rabies Immune Globulin (Equine) Sales by Country (2018-2023)
5.1.2 Americas Rabies Immune Globulin (Equine) Revenue by Country (2018-2023)
5.2 Americas Rabies Immune Globulin (Equine) Sales by Type
5.3 Americas Rabies Immune Globulin (Equine) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rabies Immune Globulin (Equine) Sales by Region
6.1.1 APAC Rabies Immune Globulin (Equine) Sales by Region (2018-2023)
6.1.2 APAC Rabies Immune Globulin (Equine) Revenue by Region (2018-2023)
6.2 APAC Rabies Immune Globulin (Equine) Sales by Type
6.3 APAC Rabies Immune Globulin (Equine) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Rabies Immune Globulin (Equine) by Country
7.1.1 Europe Rabies Immune Globulin (Equine) Sales by Country (2018-2023)
7.1.2 Europe Rabies Immune Globulin (Equine) Revenue by Country (2018-2023)
7.2 Europe Rabies Immune Globulin (Equine) Sales by Type
7.3 Europe Rabies Immune Globulin (Equine) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Rabies Immune Globulin (Equine) by Country
8.1.1 Middle East & Africa Rabies Immune Globulin (Equine) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Rabies Immune Globulin (Equine) Revenue by Country (2018-2023)
8.2 Middle East & Africa Rabies Immune Globulin (Equine) Sales by Type
8.3 Middle East & Africa Rabies Immune Globulin (Equine) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rabies Immune Globulin (Equine)
10.3 Manufacturing Process Analysis of Rabies Immune Globulin (Equine)
10.4 Industry Chain Structure of Rabies Immune Globulin (Equine)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rabies Immune Globulin (Equine) Distributors
11.3 Rabies Immune Globulin (Equine) Customer
12 World Forecast Review for Rabies Immune Globulin (Equine) by Geographic Region
12.1 Global Rabies Immune Globulin (Equine) Market Size Forecast by Region
12.1.1 Global Rabies Immune Globulin (Equine) Forecast by Region (2024-2029)
12.1.2 Global Rabies Immune Globulin (Equine) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Rabies Immune Globulin (Equine) Forecast by Type
12.7 Global Rabies Immune Globulin (Equine) Forecast by Application
13 Key Players Analysis
13.1 Grifols
13.1.1 Grifols Company Information
13.1.2 Grifols Rabies Immune Globulin (Equine) Product Portfolios and Specifications
13.1.3 Grifols Rabies Immune Globulin (Equine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Grifols Main Business Overview
13.1.5 Grifols Latest Developments
13.2 Serum China
13.2.1 Serum China Company Information
13.2.2 Serum China Rabies Immune Globulin (Equine) Product Portfolios and Specifications
13.2.3 Serum China Rabies Immune Globulin (Equine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Serum China Main Business Overview
13.2.5 Serum China Latest Developments
13.3 Premium Serums
13.3.1 Premium Serums Company Information
13.3.2 Premium Serums Rabies Immune Globulin (Equine) Product Portfolios and Specifications
13.3.3 Premium Serums Rabies Immune Globulin (Equine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Premium Serums Main Business Overview
13.3.5 Premium Serums Latest Developments
13.4 Intas
13.4.1 Intas Company Information
13.4.2 Intas Rabies Immune Globulin (Equine) Product Portfolios and Specifications
13.4.3 Intas Rabies Immune Globulin (Equine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Intas Main Business Overview
13.4.5 Intas Latest Developments
13.5 Aventis Pasteur India
13.5.1 Aventis Pasteur India Company Information
13.5.2 Aventis Pasteur India Rabies Immune Globulin (Equine) Product Portfolios and Specifications
13.5.3 Aventis Pasteur India Rabies Immune Globulin (Equine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Aventis Pasteur India Main Business Overview
13.5.5 Aventis Pasteur India Latest Developments
13.6 Cadila Pharmaceuticals
13.6.1 Cadila Pharmaceuticals Company Information
13.6.2 Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Product Portfolios and Specifications
13.6.3 Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Cadila Pharmaceuticals Main Business Overview
13.6.5 Cadila Pharmaceuticals Latest Developments
13.7 Zydus Takeda Healthcare
13.7.1 Zydus Takeda Healthcare Company Information
13.7.2 Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Product Portfolios and Specifications
13.7.3 Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Zydus Takeda Healthcare Main Business Overview
13.7.5 Zydus Takeda Healthcare Latest Developments
13.8 Bharat Serums And Vaccines
13.8.1 Bharat Serums And Vaccines Company Information
13.8.2 Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Product Portfolios and Specifications
13.8.3 Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Bharat Serums And Vaccines Main Business Overview
13.8.5 Bharat Serums And Vaccines Latest Developments
13.9 GlaxoSmithKline GmbH
13.9.1 GlaxoSmithKline GmbH Company Information
13.9.2 GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Product Portfolios and Specifications
13.9.3 GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 GlaxoSmithKline GmbH Main Business Overview
13.9.5 GlaxoSmithKline GmbH Latest Developments
13.10 VINS Bioproducts
13.10.1 VINS Bioproducts Company Information
13.10.2 VINS Bioproducts Rabies Immune Globulin (Equine) Product Portfolios and Specifications
13.10.3 VINS Bioproducts Rabies Immune Globulin (Equine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 VINS Bioproducts Main Business Overview
13.10.5 VINS Bioproducts Latest Developments
13.11 CSL Behring
13.11.1 CSL Behring Company Information
13.11.2 CSL Behring Rabies Immune Globulin (Equine) Product Portfolios and Specifications
13.11.3 CSL Behring Rabies Immune Globulin (Equine) Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 CSL Behring Main Business Overview
13.11.5 CSL Behring Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Rabies Immune Globulin (Equine) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Rabies Immune Globulin (Equine) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 1500IU
Table 4. Major Players of 1000IU
Table 5. Major Players of 400IU
Table 6. Major Players of Others
Table 7. Global Rabies Immune Globulin (Equine) Sales by Type (2018-2023) & (K Units)
Table 8. Global Rabies Immune Globulin (Equine) Sales Market Share by Type (2018-2023)
Table 9. Global Rabies Immune Globulin (Equine) Revenue by Type (2018-2023) & ($ million)
Table 10. Global Rabies Immune Globulin (Equine) Revenue Market Share by Type (2018-2023)
Table 11. Global Rabies Immune Globulin (Equine) Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Rabies Immune Globulin (Equine) Sales by Application (2018-2023) & (K Units)
Table 13. Global Rabies Immune Globulin (Equine) Sales Market Share by Application (2018-2023)
Table 14. Global Rabies Immune Globulin (Equine) Revenue by Application (2018-2023)
Table 15. Global Rabies Immune Globulin (Equine) Revenue Market Share by Application (2018-2023)
Table 16. Global Rabies Immune Globulin (Equine) Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Rabies Immune Globulin (Equine) Sales by Company (2018-2023) & (K Units)
Table 18. Global Rabies Immune Globulin (Equine) Sales Market Share by Company (2018-2023)
Table 19. Global Rabies Immune Globulin (Equine) Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Rabies Immune Globulin (Equine) Revenue Market Share by Company (2018-2023)
Table 21. Global Rabies Immune Globulin (Equine) Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Rabies Immune Globulin (Equine) Producing Area Distribution and Sales Area
Table 23. Players Rabies Immune Globulin (Equine) Products Offered
Table 24. Rabies Immune Globulin (Equine) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Rabies Immune Globulin (Equine) Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Rabies Immune Globulin (Equine) Sales Market Share Geographic Region (2018-2023)
Table 29. Global Rabies Immune Globulin (Equine) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Rabies Immune Globulin (Equine) Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Rabies Immune Globulin (Equine) Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Rabies Immune Globulin (Equine) Sales Market Share by Country/Region (2018-2023)
Table 33. Global Rabies Immune Globulin (Equine) Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Rabies Immune Globulin (Equine) Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Rabies Immune Globulin (Equine) Sales by Country (2018-2023) & (K Units)
Table 36. Americas Rabies Immune Globulin (Equine) Sales Market Share by Country (2018-2023)
Table 37. Americas Rabies Immune Globulin (Equine) Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Rabies Immune Globulin (Equine) Revenue Market Share by Country (2018-2023)
Table 39. Americas Rabies Immune Globulin (Equine) Sales by Type (2018-2023) & (K Units)
Table 40. Americas Rabies Immune Globulin (Equine) Sales by Application (2018-2023) & (K Units)
Table 41. APAC Rabies Immune Globulin (Equine) Sales by Region (2018-2023) & (K Units)
Table 42. APAC Rabies Immune Globulin (Equine) Sales Market Share by Region (2018-2023)
Table 43. APAC Rabies Immune Globulin (Equine) Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Rabies Immune Globulin (Equine) Revenue Market Share by Region (2018-2023)
Table 45. APAC Rabies Immune Globulin (Equine) Sales by Type (2018-2023) & (K Units)
Table 46. APAC Rabies Immune Globulin (Equine) Sales by Application (2018-2023) & (K Units)
Table 47. Europe Rabies Immune Globulin (Equine) Sales by Country (2018-2023) & (K Units)
Table 48. Europe Rabies Immune Globulin (Equine) Sales Market Share by Country (2018-2023)
Table 49. Europe Rabies Immune Globulin (Equine) Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Rabies Immune Globulin (Equine) Revenue Market Share by Country (2018-2023)
Table 51. Europe Rabies Immune Globulin (Equine) Sales by Type (2018-2023) & (K Units)
Table 52. Europe Rabies Immune Globulin (Equine) Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Rabies Immune Globulin (Equine) Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Rabies Immune Globulin (Equine) Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Rabies Immune Globulin (Equine) Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Rabies Immune Globulin (Equine) Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Rabies Immune Globulin (Equine) Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Rabies Immune Globulin (Equine) Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Rabies Immune Globulin (Equine)
Table 60. Key Market Challenges & Risks of Rabies Immune Globulin (Equine)
Table 61. Key Industry Trends of Rabies Immune Globulin (Equine)
Table 62. Rabies Immune Globulin (Equine) Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Rabies Immune Globulin (Equine) Distributors List
Table 65. Rabies Immune Globulin (Equine) Customer List
Table 66. Global Rabies Immune Globulin (Equine) Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Rabies Immune Globulin (Equine) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Rabies Immune Globulin (Equine) Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Rabies Immune Globulin (Equine) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Rabies Immune Globulin (Equine) Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Rabies Immune Globulin (Equine) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Rabies Immune Globulin (Equine) Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Rabies Immune Globulin (Equine) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Rabies Immune Globulin (Equine) Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Rabies Immune Globulin (Equine) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Rabies Immune Globulin (Equine) Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Rabies Immune Globulin (Equine) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Rabies Immune Globulin (Equine) Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Rabies Immune Globulin (Equine) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Grifols Basic Information, Rabies Immune Globulin (Equine) Manufacturing Base, Sales Area and Its Competitors
Table 81. Grifols Rabies Immune Globulin (Equine) Product Portfolios and Specifications
Table 82. Grifols Rabies Immune Globulin (Equine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Grifols Main Business
Table 84. Grifols Latest Developments
Table 85. Serum China Basic Information, Rabies Immune Globulin (Equine) Manufacturing Base, Sales Area and Its Competitors
Table 86. Serum China Rabies Immune Globulin (Equine) Product Portfolios and Specifications
Table 87. Serum China Rabies Immune Globulin (Equine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Serum China Main Business
Table 89. Serum China Latest Developments
Table 90. Premium Serums Basic Information, Rabies Immune Globulin (Equine) Manufacturing Base, Sales Area and Its Competitors
Table 91. Premium Serums Rabies Immune Globulin (Equine) Product Portfolios and Specifications
Table 92. Premium Serums Rabies Immune Globulin (Equine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Premium Serums Main Business
Table 94. Premium Serums Latest Developments
Table 95. Intas Basic Information, Rabies Immune Globulin (Equine) Manufacturing Base, Sales Area and Its Competitors
Table 96. Intas Rabies Immune Globulin (Equine) Product Portfolios and Specifications
Table 97. Intas Rabies Immune Globulin (Equine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Intas Main Business
Table 99. Intas Latest Developments
Table 100. Aventis Pasteur India Basic Information, Rabies Immune Globulin (Equine) Manufacturing Base, Sales Area and Its Competitors
Table 101. Aventis Pasteur India Rabies Immune Globulin (Equine) Product Portfolios and Specifications
Table 102. Aventis Pasteur India Rabies Immune Globulin (Equine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Aventis Pasteur India Main Business
Table 104. Aventis Pasteur India Latest Developments
Table 105. Cadila Pharmaceuticals Basic Information, Rabies Immune Globulin (Equine) Manufacturing Base, Sales Area and Its Competitors
Table 106. Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Product Portfolios and Specifications
Table 107. Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Cadila Pharmaceuticals Main Business
Table 109. Cadila Pharmaceuticals Latest Developments
Table 110. Zydus Takeda Healthcare Basic Information, Rabies Immune Globulin (Equine) Manufacturing Base, Sales Area and Its Competitors
Table 111. Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Product Portfolios and Specifications
Table 112. Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Zydus Takeda Healthcare Main Business
Table 114. Zydus Takeda Healthcare Latest Developments
Table 115. Bharat Serums And Vaccines Basic Information, Rabies Immune Globulin (Equine) Manufacturing Base, Sales Area and Its Competitors
Table 116. Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Product Portfolios and Specifications
Table 117. Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Bharat Serums And Vaccines Main Business
Table 119. Bharat Serums And Vaccines Latest Developments
Table 120. GlaxoSmithKline GmbH Basic Information, Rabies Immune Globulin (Equine) Manufacturing Base, Sales Area and Its Competitors
Table 121. GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Product Portfolios and Specifications
Table 122. GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. GlaxoSmithKline GmbH Main Business
Table 124. GlaxoSmithKline GmbH Latest Developments
Table 125. VINS Bioproducts Basic Information, Rabies Immune Globulin (Equine) Manufacturing Base, Sales Area and Its Competitors
Table 126. VINS Bioproducts Rabies Immune Globulin (Equine) Product Portfolios and Specifications
Table 127. VINS Bioproducts Rabies Immune Globulin (Equine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. VINS Bioproducts Main Business
Table 129. VINS Bioproducts Latest Developments
Table 130. CSL Behring Basic Information, Rabies Immune Globulin (Equine) Manufacturing Base, Sales Area and Its Competitors
Table 131. CSL Behring Rabies Immune Globulin (Equine) Product Portfolios and Specifications
Table 132. CSL Behring Rabies Immune Globulin (Equine) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. CSL Behring Main Business
Table 134. CSL Behring Latest Developments
List of Figures
Figure 1. Picture of Rabies Immune Globulin (Equine)
Figure 2. Rabies Immune Globulin (Equine) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rabies Immune Globulin (Equine) Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Rabies Immune Globulin (Equine) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Rabies Immune Globulin (Equine) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 1500IU
Figure 10. Product Picture of 1000IU
Figure 11. Product Picture of 400IU
Figure 12. Product Picture of Others
Figure 13. Global Rabies Immune Globulin (Equine) Sales Market Share by Type in 2022
Figure 14. Global Rabies Immune Globulin (Equine) Revenue Market Share by Type (2018-2023)
Figure 15. Rabies Immune Globulin (Equine) Consumed in Clinic
Figure 16. Global Rabies Immune Globulin (Equine) Market: Clinic (2018-2023) & (K Units)
Figure 17. Rabies Immune Globulin (Equine) Consumed in Hospital
Figure 18. Global Rabies Immune Globulin (Equine) Market: Hospital (2018-2023) & (K Units)
Figure 19. Global Rabies Immune Globulin (Equine) Sales Market Share by Application (2022)
Figure 20. Global Rabies Immune Globulin (Equine) Revenue Market Share by Application in 2022
Figure 21. Rabies Immune Globulin (Equine) Sales Market by Company in 2022 (K Units)
Figure 22. Global Rabies Immune Globulin (Equine) Sales Market Share by Company in 2022
Figure 23. Rabies Immune Globulin (Equine) Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Rabies Immune Globulin (Equine) Revenue Market Share by Company in 2022
Figure 25. Global Rabies Immune Globulin (Equine) Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Rabies Immune Globulin (Equine) Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Rabies Immune Globulin (Equine) Sales 2018-2023 (K Units)
Figure 28. Americas Rabies Immune Globulin (Equine) Revenue 2018-2023 ($ Millions)
Figure 29. APAC Rabies Immune Globulin (Equine) Sales 2018-2023 (K Units)
Figure 30. APAC Rabies Immune Globulin (Equine) Revenue 2018-2023 ($ Millions)
Figure 31. Europe Rabies Immune Globulin (Equine) Sales 2018-2023 (K Units)
Figure 32. Europe Rabies Immune Globulin (Equine) Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Rabies Immune Globulin (Equine) Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Rabies Immune Globulin (Equine) Revenue 2018-2023 ($ Millions)
Figure 35. Americas Rabies Immune Globulin (Equine) Sales Market Share by Country in 2022
Figure 36. Americas Rabies Immune Globulin (Equine) Revenue Market Share by Country in 2022
Figure 37. Americas Rabies Immune Globulin (Equine) Sales Market Share by Type (2018-2023)
Figure 38. Americas Rabies Immune Globulin (Equine) Sales Market Share by Application (2018-2023)
Figure 39. United States Rabies Immune Globulin (Equine) Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Rabies Immune Globulin (Equine) Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Rabies Immune Globulin (Equine) Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Rabies Immune Globulin (Equine) Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Rabies Immune Globulin (Equine) Sales Market Share by Region in 2022
Figure 44. APAC Rabies Immune Globulin (Equine) Revenue Market Share by Regions in 2022
Figure 45. APAC Rabies Immune Globulin (Equine) Sales Market Share by Type (2018-2023)
Figure 46. APAC Rabies Immune Globulin (Equine) Sales Market Share by Application (2018-2023)
Figure 47. China Rabies Immune Globulin (Equine) Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Rabies Immune Globulin (Equine) Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Rabies Immune Globulin (Equine) Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Rabies Immune Globulin (Equine) Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Rabies Immune Globulin (Equine) Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Rabies Immune Globulin (Equine) Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Rabies Immune Globulin (Equine) Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Rabies Immune Globulin (Equine) Sales Market Share by Country in 2022
Figure 55. Europe Rabies Immune Globulin (Equine) Revenue Market Share by Country in 2022
Figure 56. Europe Rabies Immune Globulin (Equine) Sales Market Share by Type (2018-2023)
Figure 57. Europe Rabies Immune Globulin (Equine) Sales Market Share by Application (2018-2023)
Figure 58. Germany Rabies Immune Globulin (Equine) Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Rabies Immune Globulin (Equine) Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Rabies Immune Globulin (Equine) Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Rabies Immune Globulin (Equine) Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Rabies Immune Globulin (Equine) Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Rabies Immune Globulin (Equine) Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Rabies Immune Globulin (Equine) Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Rabies Immune Globulin (Equine) Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Rabies Immune Globulin (Equine) Sales Market Share by Application (2018-2023)
Figure 67. Egypt Rabies Immune Globulin (Equine) Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Rabies Immune Globulin (Equine) Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Rabies Immune Globulin (Equine) Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Rabies Immune Globulin (Equine) Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Rabies Immune Globulin (Equine) Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Rabies Immune Globulin (Equine) in 2022
Figure 73. Manufacturing Process Analysis of Rabies Immune Globulin (Equine)
Figure 74. Industry Chain Structure of Rabies Immune Globulin (Equine)
Figure 75. Channels of Distribution
Figure 76. Global Rabies Immune Globulin (Equine) Sales Market Forecast by Region (2024-2029)
Figure 77. Global Rabies Immune Globulin (Equine) Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Rabies Immune Globulin (Equine) Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Rabies Immune Globulin (Equine) Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Rabies Immune Globulin (Equine) Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Rabies Immune Globulin (Equine) Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の狂犬病免疫グロブリン（馬）市場予測 2023年-2029年] (コード：LP23DC04616)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の狂犬病免疫グロブリン（馬）市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の狂犬病免疫グロブリン（ヒト）市場予測 2023年-2029年
  • 世界の回転ガンマシステム（RGS）市場予測 2023年-2029年
  • 世界の自動車用コンピュータ断層撮影法（CT）市場予測 2023年-2029年
  • 世界のプレフィルドフラッシュシリンジ（≤5ml）市場予測 2023年-2029年
  • 世界の非球面折り畳み式眼内レンズ（IOL）市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆